Endothelial dysfunction in hemodialysis patients with failed renal transplants

Clinical Transplantation

Volumn 24, Issue 5, 2010, Pages 678-684

  Gorgulu, Numan ^a   Yelken, Berna ^a   Caliskan, Yasar ^a   Elitok, Ali ^b   Cimen, Arif Oguzhan ^b   Yazici, Halil ^a   Oflaz, Huseyin ^b   Golcuk, Ebru ^b   Ekmekci, Ahmet ^b   Turkmen, Aydin ^a   Yildiz, Alaattin ^a   Sever, Mehmet Sukru ^a  

^a ISTANBUL UNIVERSITY   (Turkey)

^b ISTANBUL UNIVERSITY   (Turkey)

Author keywords

Endothelial dysfunction; Failed renal transplants; Hemodialysis patients

Indexed keywords

C REACTIVE PROTEIN; CALCIUM; CHOLESTEROL; CREATININE; SERUM ALBUMIN;

ADULT; ARTICLE; CALCIUM BLOOD LEVEL; CHOLESTEROL BLOOD LEVEL; CORONARY ARTERY; CORONARY FLOW RESERVE; CREATININE BLOOD LEVEL; ENDOTHELIAL DYSFUNCTION; FEMALE; GRAFT FAILURE; HEMATOCRIT; HEMODIALYSIS PATIENT; HUMAN; KIDNEY GRAFT; KIDNEY TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; TREATMENT DURATION;

ADOLESCENT; ADULT; AGED; CORONARY CIRCULATION; CORONARY VESSELS; CROSS-SECTIONAL STUDIES; ENDOTHELIUM, VASCULAR; FEMALE; HUMANS; INFLAMMATION; KIDNEY DISEASES; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; POSTOPERATIVE COMPLICATIONS; RENAL DIALYSIS; RISK FACTORS; VASCULAR DISEASES; YOUNG ADULT;

EID: 78650478181     PISSN: 09020063     EISSN: 13990012     Source Type: Journal    
DOI: 10.1111/j.1399-0012.2009.01160.x     Document Type: Article

References (30)

1. Ojo A, Wolfe RA, Agodoa LY et al. Prognosis after primary renal transplant failure and the beneficial effects of repeat transplantation: multivariate analyses from the United States Renal Data System. Transplantation 1998: 66: 1651.
2. United States Renal Data System. Chapter seven: Transplantation. USRDS, Minneapolis, MN, 2007.
3. Langone AJ, Chuang P. The Management of the failed renal allograft: an enigma with potential consequences. Semin Dial 2005: 18: 185.
4. Kaplan B, Meier-Kriesche HU. Death after graft loss: an important late study endpoint in kidney transplantation. Am J Transplant 2002: 2: 970.
5. Zimmermann J, Herrlinger S, Pruy A, Metzger T, Wanner C. Inflammation enhances cardiovascular risk and mortality in hemodialysis patients. Kidney Int 1999: 55: 648.
6. Arici M, Walls J. End-stage renal disease, atherosclerosis and cardiovascular mortality: is C-reactive protein the missing link? Kidney Int 2001: 59: 407.
7. Stenvinkel P, Heimburger O, Paultre F et al. Strong association between malnutrition, inflammation and atherosclerosis in chronic renal failure. Kidney Int 1999: 55: 1899.
8. Lopez-Gomez J, Perez-Flores I, Jofre R et al. Presence of a failed kidney transplant in patients who are on hemodialysis is associated with chronic inflammatory state and erythropoietin resistance. J Am Soc Nephrol 2004: 15: 2494.
9. US Renal Data System. 1998 annual report: the National Institute of Diabetes and Digestive and Kidney Diseases. Am J Kidney Dis 1998; 32 (Suppl 1): S81.
10. Anderson TJ, Uehata A, Gerhard MD et al. Close relation of endothelial function in the human coronary and peripheral circulation. J Am Coll Cardiol 1995: 26: 1235.
11. Endemann D, Schiffrin E. Endothelial dysfunction. J Am Soc Nephrol 2004: 15: 1983.
12. Stenvinkel P. Endothelial dysfunction and inflammation. Nephrol Dial Transplant 2001: 16: 1968.
13. Rigo F. Coronary flow reserve in stress-echo lab: from pathophysiologic toy to diagnostic tool. Cardiovasc Ultrasound 2005: 3: 8.
14. Gould KL, Lipscomb K. Effects of coronary stenoses on coronary flow reserve and resistance. Am J Cardiol 1974: 34: 48.
15. Thambyrajah J, Landray MJ, McGlynn FJ, Jones HJ, Wheeler DC, Townend JN. Abnormalities of endothelial function in patients with predialysis renal failure. Heart 2000: 83: 205.
16. Van Guldener C, Lambert J, Janssen MJ, Donker AJ, Stehouwer CD. Endothelium-dependent vasodilatation and distensibility of large arteries in chronic hemodialysis patients. Nephrol Dial Transplant 1997: 12(Suppl 2): 14.
17. Van Guldener C, Janssen MJ, Lambert J, Steyn M, Donker AJ, Stehouwer CD. Endothelium-dependent vasodilatation is impaired in peritoneal dialysis patients. Nephrol Dial Transplant 1998: 13: 1782.
18. Pannier B, Guerin AP, Marchais SJ, Metivier F, Safar ME, London GM. Postischemic vasodilation, endothelial activation, and cardiovascular remodeling in end-stage renal disease. Kidney Int 2000: 57: 1091.
19. Hausberg M, Kisters K, Kosch M, Rahn KH, Barenbrock M. Flow-mediated vasodilation and distensibility of the brachial artery in renal allograft recipients. Kidney Int 1999: 55: 1104.
20. Ovuworie CA, Fox ER, Chow CM et al. Vascular endothelial function in cyclosporine and tacrolimus treated renal transplant recipients. Transplantation 2001: 72: 1385.
21. Kocak H, Ceken K, Yavuz A et al. Effect of renal transplantation on endothelial dysfunction in hemodialysis patients. Nephrol Dial Transplant 2006: 21: 203.
22. Oflaz H, Turkmen A, Turgut F et al. Changes in endothelial function before and after renal transplantation. Transpl Int 2006: 19: 333.
23. Hozumi T, Yoshida K, Ogata Y et al. Noninvasive assessment of significant left anterior descending coronary artery stenosis by coronary flow velocity reserve with transthoracic color Doppler echocardiography. Circulation 1998: 97: 1557.
24. Declaration of Helsinki. Recommendations Guiding Physicians in Biomedical Research Involving Human Subjects, 41st World Medical Assembly, Hong Kong, September, 1989.
25. Kato A, Odamaki M, Maruyama Y, Maruyama Y, Kumagai H, Hishida A. Association between interleukin-6 and carotid atherosclerosis in hemodialysis patients. Kidney Int 2002: 61: 1143.
26. Tyralla K, Amann K. Morphology of the heart and arteries in renal failure. Kidney Int 2003: 63: S80.
27. Tok D, Gullu H, Erdogan D et al. Impaired coronary flow reserve in hemodialysis patients: a transthoracic Doppler echocardiographic study. Nephron Clin Pract 2005: 101: 200.
28. Bolton CH, Downs LG, Victory JG et al. Endothelial dysfunction in chronic renal failure: roles of lipoprotein oxidation and pro-inflammatory cytokines. Nephrol Dial Transplant 2001: 16: 1189.
29. Smak Gregoor PJ, Zietse R, Van Saase JL et al. Immunosuppression should be stopped in patients with renal allograft failure. Clin Transplant 2001: 15: 397.
30. Almond MK, Tailor D, Marsh FP, Raftery MJ, Cunningham J. Increased erythropoietin requirements in patients in patents with failed renal transplants returning to a dialysis programme. Nephrol Dial Transplant 1994: 9: 270.